The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most patients. Surgery is also the main treatment for medullary thyroid carcinoma, and kinase inhibitors may be appropriate for select patients with recurrent or persistent disease that is not resectable. Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. When systemic therapy is indicated, targeted therapy options are preferred. This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, and surgical management of differentiated thyroid carcinoma (papillary, follicular, Hürthle cell carcinoma).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Self-citationEgner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714448 · Cited by 2,824
Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H. C., Kindler, H. L., Lopez-Martin, J. A., Miller, W. H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30445-9 · Cited by 2,552
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790
Current Thyroid Cancer Trends in the United States
Davies, L., & Welch, H. G. (2014) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.1 · Cited by 1,615
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,559
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Cabozantinib in Progressive Medullary Thyroid Cancer
Elisei, R., Schlumberger, M. J., Müller, S. P., Schöffski, P., Brose, M. S., Shah, M. H., Licitra, L., Jarzab, B., Medvedev, V., Kreissl, M. C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4659 · Cited by 1,217
Self-citationThe Importance of Surgeon Experience for Clinical and Economic Outcomes From Thyroidectomy
Sosa, J. A., Bowman, H. M., Tielsch, J. M., Powe, N. R., Gordon, T. A., & Udelsman, R. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00005 · Cited by 1,118
Werner & Ingbar's the thyroid : a fundamental and clinical text
Werner, S. C., Ingbar, S. H., Braverman, L. E., & Utiger, R. D. (2012) · Lippincott-Raven eBooks · Cited by 1,016
Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
Chen, A. Y., Jemal, A., & Ward, E. M. (2009) · Cancer · doi:10.1002/cncr.24416 · Cited by 988
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Smallridge, R. C., Ain, K. B., Asa, S. L., Bible, K. C., Brierley, J. D., Burman, K. D., Kebebew, E., Lee, N. Y., Nikiforov, Y. E., Rosenthal, M. S., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0302 · Cited by 935
Sherma, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12488-9 · Cited by 925
Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Cho, J. Y., Schellens, J. H. M., Soria, J. C., Wen, P. Y., Zielinski, C., Cabanillas, M. E., Urbanowitz, G., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.6785 · Cited by 892
Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline
Lutz, S., Berk, L., Chang, E., Chow, E., Hahn, C., Hoskin, P., Howell, D., Konski, A., Kachnic, L., Lo, S., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.026 · Cited by 863
Ito, Y., Miyauchi, A., Kihara, M., Higashiyama, T., Kobayashi, K., & Miya, A. (2014) · Thyroid · doi:10.1089/thy.2013.0367 · Cited by 826
Enewold, L., Zhu, K., Ron, E., Marrogi, A. J., Stojadinovic, A., Peoples, G. E., & Devesa, S. S. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0960 · Cited by 809
Gilliland, F. D., Hunt, W. C., Morris, D. M., & Key, C. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0 · Cited by 803
Efficacy of Selpercatinib in RET -Altered Thyroid Cancers
Wirth, L. J., Sherman, E., Robinson, B., Solomon, B., Kang, H., Lorch, J., Worden, F., Brose, M., Patel, J., Leboulleux, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2005651 · Cited by 790
Self-citationBible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0944 · Cited by 730
Rosen, L. S., Gordon, D., Tchekmedyian, N. S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2004) · Cancer · doi:10.1002/cncr.20308 · Cited by 705
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Stewart, A. K., Winchester, D. P., Talamonti, M. S., & Sturgeon, C. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e31814697d9 · Cited by 697
Self-citationOutcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
Jonklaas, J., Sarlis, N. J., Litofsky, D., Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., Haugen, B. R., Ladenson, P. W., Magner, J., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.1229 · Cited by 695
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Schlumberger, M., Catargi, B., Borget, I., Deandreis, D., Zerdoud, S., Bridji, B., Bardet, S., Leenhardt, L., Bastie, D., Schvartz, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108586 · Cited by 684
Anaplastic thyroid carcinoma: Treatment outcome and prognostic factors
Kebebew, E., Greenspan, F. S., Clark, O. H., Woeber, K. A., & McMillan, A. (2005) · Cancer · doi:10.1002/cncr.20936 · Cited by 666
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Mallick, U., Harmer, C., Yap, B., Wadsley, J., Clarke, S., Moss, L., Nicol, A., Clark, P. M., Farnell, K., McCready, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109589 · Cited by 615
Carty, S. E., Cooper, D. S., Doherty, G. M., Duh, Q.-Y., Kloos, R. T., Mandel, S. J., Randolph, G. W., Stack, B. C., Steward, D. L., Terris, D. J., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0159 · Cited by 609
Self-citationHypocalcemia following Thyroid Surgery: Incidence and Prediction of Outcome
Pattou, F., Combemale, F., Fabre, S., Carnaille, B., Decoulx, M., Wemeau, J., Racadot, A., & Proye, C. (1998) · World Journal of Surgery · doi:10.1007/s002689900459 · Cited by 559
Kurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4145 · Cited by 550
Self-citationEarly Malignant Progression of Hereditary Medullary Thyroid Cancer
Machens, A., Niccoli-Sire, P., Hoegel, J., Frank-Raue, K., van Vroonhoven, T. J., Roeher, H.-D., Wahl, R. A., Lamesch, P., Raue, F., Conte-Devolx, B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012915 · Cited by 545
Wells, S. A., Gosnell, J. E., Gagel, R. F., Moley, J., Pfister, D., Sosa, J. A., Skinner, M., Krebs, A., Vasselli, J., & Schlumberger, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6604 · Cited by 519
RET revisited: expanding the oncogenic portfolio
Mulligan, L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3680 · Cited by 513
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
McIver, B., HAY, I. D., Giuffrida, D., et al. (2001) · Surgery · doi:10.1067/msy.2001.118266 · Cited by 484
Self-citationNatural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
Tuttle, R. M., Fagin, J. A., Minkowitz, G., Wong, R. J., Roman, B., Patel, S., Untch, B., Ganly, I., Shaha, A. R., Shah, J. P., et al. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.1442 · Cited by 484
Self-citationShimaoka, K., Schoenfeld, D. A., Dewys, W. D., Creech, R. H., & Deconti, R. (1985) · Cancer · doi:10.1002/1097-0142(19851101)56:9<2155::aid-cncr2820560903>3.0.co;2-e · Cited by 464
Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
Aschebrook-Kilfoy, B., Ward, M. H., Sabra, M. M., & Devesa, S. S. (2011) · Thyroid · doi:10.1089/thy.2010.0021 · Cited by 454
Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches
Are, C., & Shaha, A. R. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.042 · Cited by 440
Adam, M. A., Pura, J., Gu, L., Dinan, M. A., Tyler, D. S., Reed, S. D., Scheri, R., Roman, S. A., & Sosa, J. A. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000925 · Cited by 427
Self-citationCarr, L. L., Mankoff, D. A., Goulart, B. H., Eaton, K. D., Capell, P. T., Kell, E. M., Bauman, J. E., & Martins, R. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0994 · Cited by 422
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0154 · Cited by 390
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
Skinner, M. A., Moley, J. A., Dilley, W. G., Owzar, K., DeBenedetti, M. K., & Wells, S. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043999 · Cited by 381
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Lam, E. T., Ringel, M. D., Kloos, R. T., Prior, T. W., Knopp, M. V., Liang, J., Sammet, S., Hall, N. C., Wakely, P. E., Vasko, V. V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0068 · Cited by 377
Subbiah, V., Hu, M. I., Wirth, L. J., Schuler, M., Mansfield, A. S., Curigliano, G., Brose, M. S., Zhu, V. W., Leboulleux, S., Bowles, D. W., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00120-0 · Cited by 366
Self-citationPD-1 Blockade in Anaplastic Thyroid Carcinoma
Capdevila, J., Wirth, L. J., Ernst, T., Ponce Aix, S., Lin, C.-C., Ramlau, R., Butler, M. O., Delord, J.-P., Gelderblom, H., Ascierto, P. A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02727 · Cited by 353
Self-citationOda, H., Miyauchi, A., Ito, Y., Yoshioka, K., Nakayama, A., Sasai, H., Masuoka, H., Yabuta, T., Fukushima, M., Higashiyama, T., et al. (2016) · Thyroid · doi:10.1089/thy.2015.0313 · Cited by 332
Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases
Matsuzu, K., Sugino, K., Masudo, K., Nagahama, M., Kitagawa, W., Shibuya, H., Ohkuwa, K., Uruno, T., Suzuki, A., Magoshi, S., et al. (2014) · World Journal of Surgery · doi:10.1007/s00268-013-2224-1 · Cited by 331
Hay, I. D., Grant, C. S., Bergstralh, E. J., Thompson, G. B., van Heerden, J. A., & Goellner, J. R. (1998) · Surgery · doi:10.1016/s0039-6060(98)70035-2 · Cited by 329
Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
Nagaiah, G., Hossain, A., Mooney, C. J., Parmentier, J., & Remick, S. C. (2011) · Journal of Oncology · doi:10.1155/2011/542358 · Cited by 317
Viola, D., Materazzi, G., Valerio, L., Molinaro, E., Agate, L., Faviana, P., Seccia, V., Sensi, E., Romei, C., Piaggi, P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3825 · Cited by 312
Grégoire, V., & Mackie, T. R. (2011) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2011.04.003 · Cited by 305
Papillary Microcarcinoma of the Thyroid: How Should It Be Treated?
Ito, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., & Miyauchi, A. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7644-5 · Cited by 296
Ain, K. B., Egorin, M. J., DeSimone, P. A., & Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group* (2000) · Thyroid · doi:10.1089/thy.2000.10.587 · Cited by 295
Kouvaraki, M. A., Shapiro, S. E., Perrier, N. D., Cote, G. J., Gagel, R. F., Hoff, A. O., Sherman, S. I., Lee, J. E., & Evans, D. B. (2005) · Thyroid · doi:10.1089/thy.2005.15.531 · Cited by 288
BRIERLEY, J., TSANG, R., SIMPSON, W. J., GOSPODAROWICZ, M., SUTCLIFFE, S., & PANZARELLA, T. (1996) · Thyroid · doi:10.1089/thy.1996.6.305 · Cited by 278
Prognostic factors and risk group analysis in follicular carcinoma of the thyroid
Shaha, A. R., Loree, T. R., & Shah, J. P. (1995) · Surgery · doi:10.1016/s0039-6060(05)80124-2 · Cited by 273
Self-citationKelly, L. M., Barila, G., Liu, P., Evdokimova, V. N., Trivedi, S., Panebianco, F., Gandhi, M., Carty, S. E., Hodak, S. P., Luo, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321937111 · Cited by 271
Anaplastic Thyroid Carcinoma: Behavior, Biology, and Therapeutic Approaches
AIN, K. B. (1998) · Thyroid · doi:10.1089/thy.1998.8.715 · Cited by 265
Niccoli, P. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.338 · Cited by 262
Li, N., Du, X. L., Reitzel, L. R., Xu, L., & Sturgis, E. M. (2013) · Thyroid · doi:10.1089/thy.2012.0392 · Cited by 262
Robinson, B. G., Paz-Ares, L., Krebs, A., Vasselli, J., & Haddad, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2461 · Cited by 257
Self-citationSchlumberger, M., Jarzab, B., Cabanillas, M. E., Robinson, B., Pacini, F., Ball, D. W., McCaffrey, J., Newbold, K., Allison, R., Martins, R. G., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1127 · Cited by 247
Self-citationSchlumberger, M., Elisei, R., Müller, S., Schöffski, P., Brose, M., Shah, M., Licitra, L., Krajewska, J., Kreissl, M. C., Niederle, B., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx479 · Cited by 240
Self-citationCiampi, R., Romei, C., Ramone, T., Prete, A., Tacito, A., Cappagli, V., Bottici, V., Viola, D., Torregrossa, L., Ugolini, C., et al. (2019) · iScience · doi:10.1016/j.isci.2019.09.030 · Cited by 239
Haigh, P. I., Urbach, D. R., & Rotstein, L. E. (2005) · Annals of Surgical Oncology · doi:10.1007/s10434-004-1165-1 · Cited by 237
Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy
Kim, J. H., & Leeper, R. D. (1987) · Cancer · doi:10.1002/1097-0142(19871115)60:10<2372::aid-cncr2820601004>3.0.co;2-1 · Cited by 232
Chatal, J.-F., Campion, L., Kraeber-Bodéré, F., Bardet, S., Vuillez, J.-P., Charbonnel, B., Rohmer, V., Chang, C.-H., Sharkey, R. M., Goldenberg, D. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4917 · Cited by 232
Wang, J. R., Zafereo, M. E., Dadu, R., Ferrarotto, R., Busaidy, N. L., Lu, C., Ahmed, S., Gule-Monroe, M. K., Williams, M. D., Sturgis, E. M., et al. (2019) · Thyroid® · doi:10.1089/thy.2019.0133 · Cited by 230
Self-citationVergamini, L. B., Frazier, A. L., Abrantes, F. L., Ribeiro, K. B., & Rodriguez-Galindo, C. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.059 · Cited by 227
De Crevoisier, R., Baudin, E., Bachelot, A., Leboulleux, S., Travagli, J.-P., Caillou, B., & Schlumberger, M. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.032 · Cited by 221
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
Savvides, P., Nagaiah, G., Lavertu, P., Fu, P., Wright, J. J., Chapman, R., Wasman, J., Dowlati, A., & Remick, S. C. (2013) · Thyroid · doi:10.1089/thy.2012.0103 · Cited by 219
The Impact of Age and Gender on Papillary Thyroid Cancer Survival
Jonklaas, J., Nogueras-Gonzalez, G., Munsell, M., Litofsky, D., Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., Haugen, B. R., Ladenson, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2864 · Cited by 212
Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
Wohllk, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3740 · Cited by 204
Thyroid Cancer Survival in the United States: Observational Data From 1973 to 2005
Davies, L., & Welch, H. G. (2010) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archoto.2010.55 · Cited by 203
The incidence of bilateral well‐differentiated thyroid cancer found at completion thyroidectomy
Pasieka, J. L., Thompson, N. W., McLeod, M. K., Burney, R. E., & Macha, M. (1992) · World Journal of Surgery · doi:10.1007/bf02067365 · Cited by 182
Mooney, C. J., Nagaiah, G., Fu, P., Wasman, J. K., Cooney, M. M., Savvides, P. S., Bokar, J. A., Dowlati, A., Wang, D., Agarwala, S. S., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0321 · Cited by 180
A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer
Bible, K. C., Suman, V. J., Menefee, M. E., Smallridge, R. C., Molina, J. R., Maples, W. J., Karlin, N. J., Traynor, A. M., Kumar, P., Goh, B. C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1520 · Cited by 175
SAMAAN, N. A., SCHULTZ, P. N., & HICKEY, R. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-801 · Cited by 167
(GETC), A. T. G. D. D. T. A. C., Schlumberger, M., Abdelmoumene, N., Delisle, M., & Couette, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.73 · Cited by 167
Molinaro, E., Campopiano, M. C., Pieruzzi, L., Matrone, A., Agate, L., Bottici, V., Viola, D., Cappagli, V., Valerio, L., Giani, C., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz113 · Cited by 160
Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma
Rao, S. N., Zafereo, M., Dadu, R., Busaidy, N. L., Hess, K. R., Cote, G. J., Williams, M. D., William, W. N., Sandulache, V. C., Gross, N. D., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0395 · Cited by 154
Self-citationHong, D. S., Bauer, T. M., Lee, J. J., Dowlati, A., Brose, M. S., Farago, A. F., Taylor, M. H., Shaw, A. T., Montez, S., Meric‐Bernstam, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy539 · Cited by 153
Thornton, K. A., Kim, G., Maher, V. E., Chattopadhyay, S., Tang, S. W., Moon, Y. J., Song, P., Marathe, A., Balakrishnan, S., Zhu, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0411 · Cited by 152
Sosa, J. A., Elisei, R., Jarząb, B., Balkissoon, J., Lu, S.-P., Bal, C., Marur, S., Gramza, A. W., Ben‐Yosef, R., Gitlitz, B. J., et al. (2013) · Thyroid · doi:10.1089/thy.2013.0078 · Cited by 151
Yu, G., Li, J. C.-L., Branovan, D. I., McCormick, S. A., & Schantz, S. P. (2010) · Thyroid · doi:10.1089/thy.2008.0281 · Cited by 149
Multikinase inhibitors: a new option for the treatment of thyroid cancer
Gild, M. L., Bullock, M., Robinson, B. G., & Clifton-Bligh, R. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.141 · Cited by 140
Follicular Thyroid Cancer Incidence Patterns in the United States, 1980–2009
Aschebrook‐Kilfoy, B., Grogan, R. H., Ward, M. H., Kaplan, E. L., & Devesa, S. S. (2013) · Thyroid · doi:10.1089/thy.2012.0356 · Cited by 137
Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid
Chindris, A.-M., Casler, J. D., Bernet, V. J., Rivera, M., Thomas, C., Kachergus, J. M., Necela, B. M., HAY, I. D., Westphal, S. A., Grant, C. S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1634 · Cited by 135
Self-citationA Phase II Study of Imatinib in Patients with Advanced Anaplastic Thyroid Cancer
Ha, H. T., Lee, J. J., Urba, S. G., Koenig, R. J., Sisson, J. C., Giordano, T. J., & Worden, F. P. (2010) · Thyroid · doi:10.1089/thy.2010.0057 · Cited by 129
Low risk papillary thyroid cancer
Brito, J. P., HAY, I. D., & Morris, J. C. (2014) · BMJ · doi:10.1136/bmj.g3045 · Cited by 127
Elisei, R., Alevizaki, M. K., Conte‐Devolx, B., Frank‐Raue, K., Leite, V. A. P. H., & Williams, G. R. (2012) · European Thyroid Journal · doi:10.1159/000346174 · Cited by 122
Bible, K. C., Suman, V. J., Molina, J. R., Smallridge, R. C., Maples, W. J., Menefee, M. E., Rubin, J., Karlin, N. J., Sideras, K., Morris, J. C., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3713 · Cited by 120
Self-citationChemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer
Orlandi, F., Caraci, P., Berruti, A., Puligheddu, B., Pivano, G., Dogliotti, L., & Angeli, A. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058984 · Cited by 119
Cady, B. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00162-1 · Cited by 119
Vitale, G., Fonderico, F., Martignetti, A., Caraglia, M., Ciccarelli, A., Nuzzo, V., Abbruzzese, A., & Lupoli, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1832 · Cited by 119
Sippel, R. S., Robbins, S. E., Poehls, J. L., Pitt, S. C., Chen, H., LEVERSON, G. E., Long, K. L., Schneider, D. F., & Connor, N. P. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004345 · Cited by 116
Self-citationRavaud, A., de la Fouchardière, C., Caron, P. J., Doussau, A., Cao, C. D., Asselineau, J., Rodien, P., Pouessel, D., Nicolli-Sire, P., Klein, M., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.01.029 · Cited by 115
Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension
Mete, Ö., ROTSTEIN, L. E., & Asa, S. L. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0832-7 · Cited by 111
A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
Chou, A. S. Y., Fraser, S., Toon, C. W., Clarkson, A., Sioson, L., Farzin, M., Cussigh, C., Aniss, A. M., O’Neill, C. J., Watson, N., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000368 · Cited by 110
Papillary Thyroid Microcarcinoma: An Over‐Treated Malignancy?
Wang, T. S., Goffredo, P., Sosa, J. A., & Roman, S. A. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2602-3 · Cited by 109
Self-citationSorafenib in Metastatic Thyroid Cancer: A Systematic Review
Thomas, L., Lai, S. Y., Dong, W., Feng, L., Dadu, R., Regone, R. M., & Cabanillas, M. E. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0362 · Cited by 109
Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers
Sherman, S. I. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0923 · Cited by 105
Long-Term Outcomes of Surgical Treatment for Hereditary Pheochromocytoma
Grubbs, E. G., Rich, T. A., Ng, C. S., Bhosale, P., Jiménez, C., Evans, D. B., Lee, J. E., & Perrier, N. D. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.10.012 · Cited by 96
Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
Ds, O., O’Brien, T., Al, W., Gharib, H., HAY, I. D., Cs, G., & van Heerden, J. A. (1994) · PubMed · Cited by 96
Management of Anaplastic Thyroid Cancer
Tennvall, J., Lundell, G. E. F., & Wallin, G. (2006) · Springer eBooks · doi:10.1007/1-84628-013-3_31 · Cited by 95
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
Pérot, G., Soubeyran, I., Ribeiro, A., Bonhomme, B., Savagner, F., Boutet-Bouzamondo, N., Hostein, I., Bonichon, F., Godbert, Y., & Chibon, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087170 · Cited by 94
Alemán, J. O., Farooki, A., & Girotra, M. (2014) · Endocrine Related Cancer · doi:10.1530/erc-12-0400 · Cited by 93
Approach to the Patient with Anaplastic Thyroid Carcinoma
Smallridge, R. C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1314 · Cited by 90
Aschebrook‐Kilfoy, B., Kaplan, E. L., Chiu, B. C. ‐., Angelos, P., & Grogan, R. H. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2892-y · Cited by 89
Carhill, A. A., Cabanillas, M. E., Jiménez, C., Waguespack, S. G., Habra, M. A., Hu, M. I.-N., Ying, A. K., Vassilopoulou‐Sellin, R., Gagel, R. F., Sherman, S. I., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2909 · Cited by 88
Self-citationChallenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer
Cabanillas, M. E., Hu, M. I.-N., Durand, J., & Busaidy, N. L. (2011) · Journal of Thyroid Research · doi:10.4061/2011/985780 · Cited by 86
Self-citationSalaün, P., Campion, L., Bournaud, C., Faivre-Chauvet, A., Vuillez, J.-P., Taïeb, D., Ansquer, C., Rousseau, C., Borson‐Chazot, F., Bardet, S., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.101865 · Cited by 85
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
Cerrato, A., Falco, V. D., & Santoro, M. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0024 · Cited by 82
Hodak, S. P., & Burman, K. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031983 · Cited by 74
Hesselink, E. N. K., Steenvoorden, D. P. T., Kapiteijn, E., Corssmit, E. P. M., van der Horst‐Schrivers, A. N. A., Lefrandt, J. D., Links, T. P., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0788 · Cited by 70
Gruber, J. J., & Colevas, A. D. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0313 · Cited by 69
Kreissl, M. C., Bastholt, L., Elisei, R., Haddad, R. I., Hauch, O., Jarząb, B., Robinson, B. G., Colzani, R., Foster, M. C., Weiss, R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02790 · Cited by 65
Self-citationRisks of complication following thyroidectomy
Burge, M. R., Zeise, T. M., Johnsen, M. W., Conway, M. J., & Qualls, C. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00004.x · Cited by 61
Thyroid dysfunctions induced by tyrosine kinase inhibitors
Fallahi, P., Ferrari, S. M., Vita, R., Di Domenicantonio, A., Corrado, A., Benvenga, S., & Antonelli, A. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.913021 · Cited by 60
Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies
Çakır, M., & Grossman, A. B. (2009) · Neuroendocrinology · doi:10.1159/000220827 · Cited by 56
Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma
Nachalon, Y., Shavit, S. S., Bachar, G. Y., Shvero, J., Limon, D., & Popovtzer, A. (2015) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2015.2332 · Cited by 55
The Role of External Beam Radiation and Targeted Therapy in Thyroid Cancer
Brierley, J. D., & Sherman, E. J. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2012.03.010 · Cited by 51
Niederle, B., Sebag, F. A., & Brauckhoff, M. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1139-5 · Cited by 46
Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
Santarpia, L., Ye, L., & Gagel, R. F. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02112.x · Cited by 45
Evaluation of Thyroid Incidentaloma
Wilhelm, S. M. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.004 · Cited by 42
Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope
Deshpande, H. A., Gettinger, S. N., & Sosa, J. A. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f28373 · Cited by 40
Response to Sunitinib in Medullary Thyroid Cancer
Kelleher, F. C., & McDermott, R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-7-200804010-00027 · Cited by 38
Managing Thyroid Microcarcinomas
Mazzaferri, E. L. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.1 · Cited by 36
Sherman, S. I. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.03.442 · Cited by 33
Impact of Surgical Treatment on Outcomes for Papillary Thyroid Cancer
Bilimoria, K. Y., Zanocco, K. A., & Sturgeon, C. (2008) · Advances in Surgery · doi:10.1016/j.yasu.2008.03.001 · Cited by 32
Self-citationNew Targeted Therapies for Anaplastic Thyroid Cancer
Antonelli, A., Fallahi, P., Ulisse, S., Ferrari, S. M., Minuto, M. N., Saraceno, G., Santini, F., Mazzi, V., D’Armiento, M., & Miccoli, P. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012798764732 · Cited by 32
Cabozantinib approved for advanced medullary thyroid cancer
Traynor, K. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/news130005 · Cited by 28
Liu, W., Yan, X., & Cheng, R. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.08.014 · Cited by 20
Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature
Gulati, A. P., Krantz, B. A., Moss, R. A., Moyal, W. N., Tsushima, D. A., Mowatt, K. B., Schreibman, S. M., & Fine, R. L. (2012) · Oncology · doi:10.1159/000342961 · Cited by 15
Multimodal approach to anaplastic thyroid cancer.
Burnison, C. M., & Lim, S. (2012) · PubMed · Cited by 11
Vuong, H. G., Ho, A. T. N., Tran, T. T. K., et al. (2019) · Head & Neck · doi:10.1002/hed.25832 · Cited by 11
Laryngeal Exam Indications and Techniques
Sinclair, C. F., Duke, W. S., Barbu, A. M., & Randolph, G. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-27727-1_2 · Cited by 6
Cited by
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Self-citation
Metadata
- Authors
- Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., Goldner, W. S., Guo, T., Haymart, M., Holt, S., Hunt, J. P., Iagaru, A., Kandeel, F., Lamonica, D. M., Mandel, S., Markovina, S., McIver, B., Raeburn, C. D., Rezaee, R., Ridge, J. A., Roth, M. Y., Scheri, R. P., Shah, J. P., Sipos, J. A., Sippel, R., Sturgeon, C., Wang, T. N., Wirth, L. J., Wong, R. J., Yeh, M., Cassara, C. J., & Darlow, S.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2022-08
- Volume
- 20
- Issue
- 8
- Pages
- 925-951
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4291019388
- Cited by
- 510
- References
- 148
- FWCI
- 62.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.